体外診断 (IVD) アナライザー：世界市場

世界の体外診断 (IVD) アナライザーの市場規模は、2023年の129億米ドルから、予測期間中は4.7%のCAGRで推移し、2028年には163億米ドルの規模に成長すると予測されています。

免疫測定分析装置の部門は2023年の38億米ドルから、4.5%のCAGRで推移し、2028年には47億米ドルに達すると予測されています。また、臨床化学分析装置の部門は2023年の29億米ドルから、3.4%のCAGRで推移し、2028年には34億米ドルに達すると予測されています。

当レポートでは、世界の体外診断 (IVD) アナライザーの市場を調査し、市場の定義・概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、技術・特許の動向、ESGの展開、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場概要

第4章 市場力学

• 市場力学
• 市場促進要因
• 市場の課題

第5章 市場内訳：アナライザータイプ別

• 世界のIVDアナライザー市場
• 市場分析
• 免疫測定分析装置
• 市場規模・予測
• 臨床化学分析装置
• 市場予測
• 血液・止血分析装置
• 市場予測
• 分子診断分析装置
• 市場予測
• ポイントオブケア分析装置
• 市場予測
• その他のアナライザー
• 市場予測

第6章 市場内訳：自動化レベル別

• 半自動分析装置
• 完全自動分析装置

第7章 市場内訳：治療領域別

• 感染症
• 糖尿病
• 腫瘍
• 心臓病
• 腎臓
• その他

第8章 市場内訳：エンドユーザー別

• 診断ラボ
• 病院・診療所
• 研究機関
• その他

第9章 市場内訳：地域別

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• ドイツ
• 英国
• フランス
• その他の欧州
• アジア太平洋
• 中国
• オーストラリア
• 日本
• その他のアジア太平洋
• 世界のその他の地域

第10章 ESGの開発

• ESG：イントロダクション
• IVDアナライザー業界の持続可能性：ESGの観点
• ESGの主要な問題
• IVD企業の環境パフォーマンス
• 主要IVDアナライザー企業の社会的パフォーマンス
• IVDアナライザー企業のガバナンス実績
• IVDアナライザー市場におけるESGに対する消費者の態度
• ケーススタディ
• BCCによる総論

第11章 新たな技術と開発

• 市場における技術
• AIと機械学習の統合
• デジタル形態学
• コネクテッドPoCデバイス
• マイクロ流体工学と小型化

第12章 規制シナリオ

• 北米のIVD規制
• 米国
• カナダ
• メキシコ
• 欧州のIVD規制
• アジア太平洋におけるIVD規制
• 日本
• 中国
• インド
• オーストラリア
• マレーシア
• シンガポール
• その他の地域におけるIVD規制
• ブラジル
• イスラエル
• サウジアラビア
• 南アフリカ

第13章 M&A分析

第14章 競合情勢

• 市場シェア分析
• 提携・協力

第15章 企業プロファイル

• ABBOTT DIAGNOSTICS SCARBOROUGH INC.
• BECTON, DICKINSON AND CO.
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• DANAHER CORP.
• EKF DIAGNOSTICS HOLDINGS PLC
• F. HOFFMANN-LA ROCHE LTD.
• QUIDELORTHO CORP.
• SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
• SIEMENS HEALTHINEERS AG
• SYSMEX CORP.
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table A : Global Market for IVD Analyzers, by Analyzer Type, Through 2028
• Summary Table B : Global Market for IVD Analyzers, by Region, Through 2028
• Table 1 : Global Market for IVD Analyzers, by Analyzer Type, Through 2028
• Table 2 : Global Market for Immunoassay Analyzers, by Region, Through 2028
• Table 3 : Analytes Tested in Clinical Chemistry Laboratories
• Table 4 : Global Market for Clinical Chemistry Analyzers, by Region, Through 2028
• Table 5 : Global Market for Hematology and Hemostasis Analyzers, by Region, Through 2028
• Table 6 : Global Market for Molecular Diagnostic Analyzers, by Region, Through 2028
• Table 7 : Global Market for PoC Analyzers, by Region, Through 2028
• Table 8 : Global Market for Other Analyzers, by Region, Through 2028
• Table 9 : Global Market for IVD Analyzers, by Level of Automation, Through 2028
• Table 10 : Global Market for Semi-automated Analyzers, by Region, Through 2028
• Table 11 : Global Market for Fully Automated Analyzers, by Region, Through 2028
• Table 12 : Global Market for IVD Analyzers, by Therapeutic Area, Through 2028
• Table 13 : Global Market for IVD Analyzers for Infectious Diseases, by Region, Through 2028
• Table 14 : Global Market for IVD Analyzers for Diabetes, by Region, Through 2028
• Table 15 : Global Market for IVD Analyzers for Oncology, by Region, Through 2028
• Table 16 : Global Market for IVD Analyzers for Cardiology, by Region, Through 2028
• Table 17 : Global Market for IVD Analyzers for Nephrology, by Region, Through 2028
• Table 18 : Global Market for IVD Analyzers for Other Therapeutic Areas, by Region, Through 2028
• Table 19 : Global Market for IVD Analyzers, by End User, Through 2028
• Table 20 : Global Market for IVD Analyzers Used in Diagnostic Labs, by Region, Through 2028
• Table 21 : Global Market for IVD Analyzers Used in Hospitals and Clinics, by Region, Through 2028
• Table 22 : Global Market for IVD Analyzers Used in Research Institutions, by Region, Through 2028
• Table 23 : Global Market for IVD Analyzers Used by Other End Users, by Region, Through 2028
• Table 24 : Global Market for IVD Analyzers, by Region, Through 2028
• Table 25 : North American Market for IVD Analyzers, by Country, Through 2028
• Table 26 : European Market for IVD Analyzers, by Country, Through 2028
• Table 27 : Asia-Pacific Market for IVD Analyzers, by Country, Through 2028
• Table 28 : Focus Areas in ESG Metrics
• Table 29 : ESG Rankings for Major IVD Analyzer Companies, 2023*
• Table 30 : ESG: Environmental Overview
• Table 31 : ESG: Social Overview
• Table 32 : ESG: Governance Overview
• Table 33 : bioMerieux: Certifications and Indices Received, 2022
• Table 34 : Developments in Digital Morphology, 2023
• Table 35 : Recent Developments in Connected PoC Devices, 2023
• Table 36 : Recent Developments in the Application of Microfluidics and Miniaturization, 2023
• Table 37 : M&A in the IVD Analyzer Market, 2021-2023
• Table 38 : Key Alliances and Partnerships in IVD Analyzers Market, 2021-2023
• Table 39 : Abbott Laboratories: Financials, 2021 and 2022
• Table 40 : Abbott Laboratories: Product Portfolio
• Table 41 : Becton, Dickinson, and Co.: Financials, 2021 and 2022
• Table 42 : Becton, Dickinson, and Co.: Product Portfolio
• Table 43 : bioMerieux SA: Financials, 2021 and 2022
• Table 44 : bioMerieux SA: Product Portfolio
• Table 45 : Bio-Rad Laboratories: Financials, 2021 and 2022
• Table 46 : Bio-Rad Laboratories: Product Portfolio
• Table 47 : Bio-Rad Laboratories: Recent Developments, 2022
• Table 48 : Danaher Corp.: Financials, 2021 and 2022
• Table 49 : Danaher Corp.: Product Portfolio
• Table 50 : Danaher Corp.: Recent Developments, 2023
• Table 51 : EKF Diagnostics Holdings: Financials, 2021 and 2022
• Table 52 : EKF Diagnostics Holdings: Product Portfolio
• Table 53 : EKF Diagnostics Holdings: Recent Developments, 2022
• Table 54 : F. Hoffmann-La Roche: Financials, 2021 and 2022
• Table 55 : F. Hoffmann-La Roche: Product Portfolio
• Table 56 : F. Hoffmann-La Roche: Recent Developments, 2023
• Table 57 : QuidelOrtho Corp.: Financials, 2021 and 2022
• Table 58 : QuidelOrtho Corp.: Product Portfolio
• Table 59 : QuidelOrtho Corp.: Recent Developments, 2023
• Table 60 : Shenzhen Mindray Bio-Medical Electronics: Product Portfolio
• Table 61 : Shenzhen Mindray Bio-Medical Electronics: Recent Developments, 2023
• Table 62 : Siemens Healthineers: Financials, 2021 and 2022
• Table 63 : Siemens Healthineers: Product Portfolio
• Table 64 : Siemens Healthineers.: Recent Developments, 2023
• Table 65 : Sysmex Corp.: Financials, 2021 and 2022
• Table 66 : Sysmex Corp.: Product Portfolio
• Table 67 : Sysmex Corp.: Recent Developments, 2023
• Table 68 : Thermo Fisher Scientific: Financials, 2021 and 2022
• Table 69 : Thermo Fisher Scientific: Product Portfolio
• Table 70 : Thermo Fisher Scientific: Recent Developments, 2023

List of Figures

• Summary Figure A : Global Market for IVD Analyzers, by Analyzer Type, 2020-2028
• Summary Figure B : Global Market for IVD Analyzers, by Region, 2020-2028
• Figure 1 : Role of In Vitro Diagnostics Tests
• Figure 2 : Global Market Shares of IVD Analyzers, by Analyzer Type, 2022
• Figure 3 : Global Market for Immunoassay Analyzers, by Region, 2020-2028
• Figure 4 : Global Market Shares of Immunoassay Analyzers, by Region, 2022
• Figure 5 : Global Market for Clinical Chemistry Analyzers, by Region, 2020-2028
• Figure 6 : Global Market Shares of Clinical Chemistry Analyzers, by Region, 2022
• Figure 7 : Global Market for Hematology and Hemostasis Analyzers, by Region, 2020-2028
• Figure 8 : Global Market Shares of Hematology and Hemostasis Analyzers, by Region, 2022
• Figure 9 : Global Market for Molecular Diagnostic Analyzers, by Region, 2020-2028
• Figure 10 : Global Market Shares of Molecular Diagnostic Analyzers, by Region, 2022
• Figure 11 : Global Market for PoC Analyzers, by Region, 2020-2028
• Figure 12 : Global Market Shares of PoC Analyzers, by Region, 2022
• Figure 13 : Global Market for Other Analyzers, by Region, 2020-2028
• Figure 14 : Global Market Shares of Other Analyzers, by Region, 2022
• Figure 15 : Global Market for Semi-Automated Analyzers, 2020-2028
• Figure 16 : Global Market for Fully Automated Analyzers, 2020-2028
• Figure 17 : Global Market Shares of IVD Analyzers, by Therapeutic Area, 2022
• Figure 18 : Global Market for IVD Analyzers for Infectious Diseases, 2020-2028
• Figure 19 : Global Market for IVD Analyzers for Diabetes, 2020-2028
• Figure 20 : Global Market for IVD Analyzers for Oncology, 2020-2028
• Figure 21 : Global Market for IVD Analyzers for Cardiology, 2020-2028
• Figure 22 : Global Market for IVD Analyzers for Nephrology, 2020-2028
• Figure 23 : Global Market for IVD Analyzers for Other Therapeutic Areas, 2020-2028
• Figure 24 : Global Market Shares of IVD Analyzers, by End User, 2022
• Figure 25 : Global Market for IVD Analyzers, by End User, 2020-2028
• Figure 26 : Global Market for IVD Analyzers Used in Diagnostic Labs, 2020-2028
• Figure 27 : Global Market for IVD Analyzers Used in Hospitals and Clinics, 2020-2028
• Figure 28 : Global Market for IVD Analyzers Used in Research Institutions, 2020-2028
• Figure 29 : Global Market for IVD Analyzers Used by Other End Users, 2020-2028
• Figure 30 : Global Market Shares of IVD Analyzers, by Region, 2022
• Figure 31 : North American Market Shares of IVD Analyzers, by Country, 2022
• Figure 32 : U.S. Market for IVD Analyzers, 2020-2028
• Figure 33 : Canadian Market for IVD Analyzers, 2020-2028
• Figure 34 : Mexican Market for IVD Analyzers, 2020-2028
• Figure 35 : European Market Shares of IVD Analyzers, by Country, 2022
• Figure 36 : German Market for IVD Analyzers, 2020-2028
• Figure 37 : U.K. Market for IVD Analyzers, 2020-2028
• Figure 38 : French Market for IVD Analyzers, 2020-2028
• Figure 39 : Rest of Europe Market for IVD Analyzers, 2020-2028
• Figure 40 : Asia-Pacific Market Shares of IVD Analyzers, by Country, 2022
• Figure 41 : Chinese Market for IVD Analyzers, 2020-2028
• Figure 42 : Australian Market for IVD Analyzers, 2020-2028
• Figure 43 : Japanese Market for IVD Analyzers, 2020-2028
• Figure 44 : Rest of Asia-Pacific Market for IVD Analyzers, 2020-2028
• Figure 45 : RoW Market for IVD Analyzers, 2020-2028
• Figure 46 : ESG Pillars
• Figure 47 : Advantages of ESG for IVD Analyzer Companies
• Figure 48 : ESG-Adoption Level Across All Industries, Global, 2021 and 2022
• Figure 49 : bioMerieux: ESG Aspects
• Figure 50 : bioMerieux ESG Indicators, 2022
• Figure 51 : Emerging Technologies in the IVD Analyzer Market
• Figure 52 : Global Market Shares of IVD Analyzers, by Company, 2022
• Figure 53 : Abbott Laboratories: Financials, 2021 and 2022
• Figure 54 : Abbott Laboratories: Market Share, by Business Segment, 2022
• Figure 55 : Abbott Laboratories: Market Share of Diagnostics Segment, by Region, 2022
• Figure 56 : Abbott Laboratories: Market Share of Diagnostics Segment, 2022
• Figure 57 : Becton, Dickinson, and Co.: Financials, 2021 and 2022
• Figure 58 : Becton, Dickinson and Co.: Market Share, by Region, 2022
• Figure 59 : Becton, Dickinson, and Co.: Market Share, by Business Segment, 2022
• Figure 60 : bioMerieux SA: Financials, 2021 and 2022
• Figure 61 : bioMerieux SA: Market Share, by Business Segment, 2022
• Figure 62 : bioMerieux SA: Market Share, by Region, 2022
• Figure 63 : Bio-Rad Laboratories: Financials, 2021 and 2022
• Figure 64 : Bio-Rad Laboratories: Market Share, by Business Segment, 2022
• Figure 65 : Bio-Rad Laboratories: Revenue Share, by Region, 2022
• Figure 66 : Danaher Corp.: Financials, 2021 and 2022
• Figure 67 : Danaher Corp.: Market Share, by Region, 2022
• Figure 68 : Danaher Corp.: Market Share, by Business Segment, 2022
• Figure 69 : EKF Diagnostics Holdings: Financials, 2021 and 2022
• Figure 70 : EKF Diagnostics Holdings: Market Share, by Region, 2022
• Figure 71 : EKF Diagnostics Holdings: Market Share, by Business Segment, 2022
• Figure 72 : F. Hoffmann-La Roche: Financials, 2021 and 2022
• Figure 73 : F. Hoffmann-La Roche: Market Share, by Region, 2022
• Figure 74 : F. Hoffmann-La Roche: Market Share, by Diagnostics Business Segment, 2022
• Figure 75 : QuidelOrtho Corp: Financials, 2021 and 2022
• Figure 76 : QuidelOrtho Corp.: Market Share, by Region, 2022
• Figure 77 : QuidelOrtho Corp.: Market Share, by Business Segment, 2022
• Figure 78 : Siemens Healthineers: Financials, 2021 and 2022
• Figure 79 : Siemens Healthineers: Market Share, by Business Segment, 2022
• Figure 80 : Siemens Healthineers: Market Share, by Region, 2022
• Figure 81 : Sysmex Corp.: Financials, 2021 and 2022
• Figure 82 : Sysmex Corp.: Market Share, by Region, 2022
• Figure 83 : Sysmex Corp.: Revenue Share, by Business Segment, 2022
• Figure 84 : Thermo Fisher Scientific: Financials, 2021 and 2022
• Figure 85 : Thermo Fisher Scientific: Market Share, by Region, 2022
• Figure 86 : Thermo Fisher Scientific: Market Share, by Business Segment, 2022
• Figure 87 : Thermo Fisher Scientific: Market Share, by Product Segment, 2022

Highlights:

The global market for In Vitro Diagnostics (IVD) analyzers is estimated to increase from $12.9 billion in 2023 to reach $16.3 billion by 2028, at a compound annual growth rate (CAGR) of 4.7% from 2023 through 2028.

The global market for IVD analyzers for immunoassay analyzers segment is estimated to increase from $3.8 billion in 2023 to reach $4.7 billion by 2028, at a compound annual growth rate (CAGR) of 4.5% from 2023 through 2028.

The global market for IVD analyzers for clinical chemistry analyzers segment is estimated to increase from $2.9 billion in 2023 to reach $3.4 billion by 2028, at a compound annual growth rate (CAGR) of 3.4% from 2023 through 2028.

Report Scope:

The current report highlights the current and future market potential of in vitro diagnostics analyzers along with an analysis of the drivers, restraints, challenges, and emerging trends in the market. The report segments the market for IVD analyzers based on analyzer type, level of automation, design, therapeutic area, and end user. The market is segmented into immunoassay analyzers, clinical chemistry, hematology and coagulation, molecular diagnostics, PoC analyzers and others based on test type. Based on level of automation, analyzers are categorized into semi-automated and fully automated. Based on therapeutic area, the market is segmented into infectious diseases, diabetes, oncology, cardiology, nephrology, and others. The market is segmented into diagnostic centers, hospitals and clinics, research institutions and others based on end user. The report includes profiles of the leading companies with information about their business segments, financials, product portfolios, and recent developments.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, and rest of the world (RoW). The North America region includes the U.S., Canada, and Mexico. Europe includes Germany, the U.K., France, and the rest of Europe. The Asia-Pacific region includes China, India, Japan, and the rest of Asia-Pacific.

Report Includes:

• 39 data tables and 34 additional tables
• An analysis of the global market for in vitro diagnostics (IVD) analyzers
• Analyses of global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimate of the actual market size and revenue forecast, and corresponding market share analysis by test type, level of automation, application, end user and region
• Facts and figures pertaining to the market growth drivers, opportunities and restraints, innovations and prospects, technologies, regulatory scenarios, and COVID-19's impact on the IVD industry
• Discussion of sustainability trends and factors in the IVD analyzer market, with emphasis on consumer attitudes, companies' ESG scores, future of ESG, case studies and the ESG practices of leading companies
• Overview of the emerging new technologies and patents in the market
• Analysis of the major vendors in the market as well as the competitive landscape, including company market shares, financials, M&A deals and venture fundings
• Profiles of the leading market players, including Siemens Healthineers, Abbott Laboratories, F. Hoffmann-La Roche, Bio-Rad Laboratories, Danaher Corp., and Thermo Fisher Scientific

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• What's New in this Update
• Methodology
• Information Sources
• Geographic Breakdown
• Segmentation Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary
• Highlights of the Market for IVD Analyzers

Chapter 3 Market Overview

• Overview

Chapter 4 Market Dynamics

• Market Dynamics
• Market Drivers
• Market Challenges

Chapter 5 Market Breakdown by Analyzer Type

• Global Market for IVD Analyzers
• Market Analysis
• Immunoassay Analyzers
• Market Size and Forecast
• Clinical Chemistry Analyzers
• Market Forecast
• Hematology and Hemostasis Analyzers
• Market Forecast
• Molecular Diagnostic Analyzers
• Market Forecast
• Point-of-Care Analyzers
• Market Forecast
• Other Analyzers
• Market Forecast

Chapter 6 Market Breakdown by Level of Automation

• Introduction
• Semi-Automated Analyzers
• Fully Automated Analyzers

Chapter 7 Market Breakdown by Therapeutic Area

• Introduction
• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Other Therapeutic Areas

Chapter 8 Market Breakdown by End User

• Introduction
• Diagnostic Labs
• Hospitals and Clinics
• Research Institutions
• Other Users

Chapter 9 Market Breakdown by Region

• Introduction
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Rest of Europe
• Asia-Pacific
• China
• Australia
• Japan
• Rest of Asia-Pacific
• Rest of the World

Chapter 10 ESG Development

• Introduction to ESG
• Sustainability in the IVD Analyzer Industry: An ESG Perspective
• Key ESG Issues
• Environmental Performance of IVD Companies
• Social Performance of Key IVD Analyzers Companies
• Governance Performance of IVD Analyzer Companies
• Consumer Attitudes toward ESG in the IVD Analyzer Market
• Case Study
• Concluding Remarks from BCC Research

Chapter 11 Emerging Technologies and Developments

• Technologies in the Market
• Integration of AI and Machine Learning
• Digital Morphology
• Connected PoC Devices
• Microfluidics and Miniaturization

Chapter 12 Regulatory Scenario

• IVD Regulations in North America
• United States
• Canada
• Mexico
• IVD Regulations in Europe
• IVD Regulations in Asia-Pacific
• Japan
• China
• India
• Australia
• Malaysia
• Singapore
• IVD Regulations in RoW
• Brazil
• Israel
• Saudi Arabia
• South Africa

Chapter 13 M&A Analysis

• M&A Analysis

Chapter 14 Competitive Landscape

• Market Share Analysis
• Partnerships and Alliances

Chapter 15 Company Profiles

• ABBOTT DIAGNOSTICS SCARBOROUGH INC.
• BECTON, DICKINSON AND CO.
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• DANAHER CORP.
• EKF DIAGNOSTICS HOLDINGS PLC
• F. HOFFMANN-LA ROCHE LTD.
• QUIDELORTHO CORP.
• SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
• SIEMENS HEALTHINEERS AG
• SYSMEX CORP.
• THERMO FISHER SCIENTIFIC INC.